The fundamentals of the projects remain unchanged but we have added the dilutive impact of York acquisition and the 18M options with the convertible note. We have also applied a country risk factor of 25% (0.75x NAV). We retain our Buy recommendation with a revised price target of $0.26/share.
afr article, page-7
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
